BNY Mellon (BK)
NYSEFinancialsBanks - DiversifiedSnapshot 2026-07-08
$15.01+0.33%
Close 2026-06-10 · 1-day change
Reading BK? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BK free→NYSEFinancialsBanks - DiversifiedSnapshot 2026-07-08
Reading BK? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BK free→QuarterlyIQ Insights · BK
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 0 valuation methods, at three horizons. Current price $15.01. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Around the middle on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $15 BK trades at 2× p/e, below its 15× p/e peer median. Our $97 fair value sits above the price; low confidence. Analysts: $136–$149. Not investment advice.
$136.00 – $149.00 (median $142.00) · 5 analysts · as of 2026-04-17
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Not enough peers to compare yet.
Self-history needs ~20 months of data.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| Mgmt guidance | 12M | $85.82 | 14.8 | 5.80 | Mgmt | high |
| Peer P/B | 12M | $126.24 | 1.9 | 64.80 | TTM | high |
| Peer P/FCF | 12M | $28.13 | 13.5 | 2.08 | TTM | high |
| Peer P/E | 12M | $121.04 | 14.8 | 8.18 | TTM | high |
| Peer P/S | 12M | $90.38 | 3.3 | 27.65 | TTM | high |
| PEG | 12M | $88.36 | 10.8 | 8.18 | TTM | high |
| Own P/E history | 12M | $103.92 | 12.7 | 8.18 | TTM | high |
| triangulated | 12M | $124.84 | 14.8 | 8.44 | Triangulated | high |
| Mgmt guidance | 3Y | $118.23 | 14.8 | 7.99 | Mgmt(prov.) | medium |
| Peer P/B | 3Y | $140.18 | 1.9 | 71.95 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 3Y | $3.38 | 13.5 | 0.25 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $119.81 | 3.3 | 36.65 | Analyst | medium |
| PEG | 3Y | $121.74 | 10.8 | 11.27 | Analyst | medium |
| Own P/E history | 3Y | $143.17 | 12.7 | 11.27 | Analyst | medium |
| Mgmt guidance | 5Y | $146.39 | 14.8 | 9.89 | Mgmt(prov.) | high |
| Peer P/B | 5Y | $144.80 | 1.9 | 77.15 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $144.59 | 3.3 | 44.23 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.